chondroitin sulfate Capsules 400 mg

This young, dynamic pharmaceutical company, operating in the EU, has established itself in recent years, aiming to improve access to medications and provide solutions for underserved illnesses. They are supported by well-established partners and shareholders in the health sector. The company is focused on the development and distribution of Rx products (prescription drugs) and OTC products (over-the-counter medications) across a variety of therapeutic areas, including oncology, cardiology, and others. Their primary manufacturing lines are concentrated on solid dosage forms, injectables, and oral medications. They have obtained GMP (Good Manufacturing Practice) approvals for their products in the EU, and are actively expanding their operations. The company's commitment to innovation is evidenced by their recent relocation to Barcelona, a major hub for healthcare innovation in the region.